Cancer Sensitizing Agents for Chemotherapy – serie

Targeting Cell Survival Pathways to Enhance Response to Chemotherapy

Drug Efflux Pumps in Cancer Resistance Pathways: From Molecular Recognition and Characterization to Possible Inhibition Strategies in Chemotherapy

Protein Kinase Inhibitors as Sensitizing Agents for Chemotherapy

Nitric Oxide (Donor/Induced) in Chemosensitization

Role of Nutraceuticals in Cancer Chemosensitization

Breaking Tolerance to Pancreatic Cancer Unresponsiveness to Chemotherapy

Improving the Therapeutic Ratio in Head and Neck Cancer

Overcoming Ovarian Cancer Chemoresistance

Drug Resistance in Colorectal Cancer: Molecular Mechanisms and Therapeutic Strategies

Novel Therapies in Head and Neck Cancer: Beyond the Horizon

pH-Interfering Agents as Chemosensitizers in Cancer Therapy

Biological Mechanisms and the Advancing Approaches to Overcoming Cancer Drug Resistance

Glioblastoma Resistance to Chemotherapy: Molecular Mechanisms and Innovative Reversal Strategies

Therapeutic Strategies to Overcome ALK Resistance in Cancer

New Targeting in The Reversal of Resistant Glioblastomas

Overcoming Resistance to EGFR Inhibitors in EGFR-Mutant NSCLC

Epigenetic Regulation in Overcoming Chemoresistance

Overcoming Drug Resistance in Gynecologic Cancers

Antiangiogenic Drugs as Chemosensitizers in Cancer Therapy

BTK Inhibitors as Sensitizing Agents in Solid Tumors

Therapy Resistance in Prostate Cancer

Mechanisms and Insights

Resistance in Hematologic Malignancies and Cancer

Retinoic Acids in Cancer Therapy

Mechanisms of Sensitivity, Resistance, and Methods of Delivery